Literature DB >> 17371485

Increased plasmin-alpha2-antiplasmin levels indicate activation of the fibrinolytic system in systemic amyloidoses.

B Bouma1, C Maas, B P C Hazenberg, H M Lokhorst, M F B G Gebbink.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17371485     DOI： 10.1111/j.1538-7836.2007.02457.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  6 in total

1.  Amyloidogenesis of SARS-CoV-2 Spike Protein.

Authors:  Sofie Nyström; Per Hammarström
Journal:  J Am Chem Soc       Date:  2022-05-17       Impact factor: 16.383

2.  Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation.

Authors:  Coen Maas; José W P Govers-Riemslag; Barend Bouma; Bettina Schiks; Bouke P C Hazenberg; Henk M Lokhorst; Per Hammarström; Hugo ten Cate; Philip G de Groot; Bonno N Bouma; Martijn F B G Gebbink
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

3.  Elevation of Plasmin-α2-plasmin Inhibitor Complexes in Patients with AL Amyloidosis.

Authors:  Kanji Miyazaki; Kenshi Suzuki
Journal:  Intern Med       Date:  2018-01-11       Impact factor: 1.271

Review 4.  Modulation of the Mechanisms Driving Transthyretin Amyloidosis.

Authors:  Filipa Bezerra; Maria João Saraiva; Maria Rosário Almeida
Journal:  Front Mol Neurosci       Date:  2020-12-11       Impact factor: 5.639

Review 5.  Al amyloidosis.

Authors:  Estelle Desport; Frank Bridoux; Christophe Sirac; Sébastien Delbes; Sébastien Bender; Béatrice Fernandez; Nathalie Quellard; Corinne Lacombe; Jean-Michel Goujon; David Lavergne; Julie Abraham; Guy Touchard; Jean-Paul Fermand; Arnaud Jaccard
Journal:  Orphanet J Rare Dis       Date:  2012-08-21       Impact factor: 4.123

6.  Elevation of Plasmin-α2-plasmin Inhibitor Complex Predicts the Diagnosis of Systemic AL Amyloidosis in Patients with Monoclonal Protein.

Authors:  Kazuya Ishiguro; Toshiaki Hayashi; Yoshihiro Yokoyama; Yuka Aoki; Kei Onodera; Hiroshi Ikeda; Tadao Ishida; Hiroshi Nakase
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.